Why Texas Children’s and Baylor Were Chosen for a $17.25 Million Autism Clinical Trials Initiative
The institutions were selected as one of just 12 initial sites worldwide, highlighting their growing influence in precision autism research.
Texas Children’s Hospital and Baylor College of Medicine have been awarded up to $17.25 million to join an international autism research network designed to accelerate the development of precision therapies for autistic individuals and people with related neurodevelopmental disorders. The grant places the Houston institutions among the first 12 sites worldwide selected to participate in the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an initiative funded through Aligning Research to Impact Autism (ARIA).
The announcement is significant not only because of the size of the award, but because it raises a larger question: Why were Texas Children’s and Baylor chosen?
The answer lies in more than a decade of investment in autism genetics, neuroscience and clinical care.
According to ARIA, the IMPACT Network was created to address a longstanding challenge in autism research. While scientists have made substantial progress identifying genes and biological pa…
